Clinical Trial

Heidelberg Registry for Hip and Knee Joint Implants and Revisions

Study acronym: EPR-HD
Recruiting
View on ClinicalTrials.gov →
Summary
The Endoprosthesis Registry Heidelberg (EPR-HD) is a clinical registry designed to systematically collect and analyze data from patients undergoing primary implantation or revision surgery of artificial hip and knee joints. The main objective of the registry is to evaluate long-term outcomes, complication rates, implant survival, and functional results associated with joint replacement procedures in patients with various hip and knee joint pathologies. By gathering comprehensive clinical data, EPR-HD aims to improve the understanding of patient outcomes after endoprosthetic procedures, identify potential factors influencing implant success, and support evidence-based improvements in surgical techniques and patient care. The registry includes adult patients treated at Heidelberg University Hospital, with data collected at multiple time points during routine clinical follow-up. This registry will contribute to the optimization of joint replacement strategies and promote high-quality patient care.
Trial Details
NCT Number NCT06850818
Lead Sponsor University Hospital Heidelberg
Conditions Osteoarthritis, Arthroplasty
Enrollment 10,000 participants
Start Date 2007-01-01
Primary Completion 2035-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-11